Tigress Financial Maintains Buy on Legence, Raises Price Target to $130
Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $125 to $130.
Read original at benzingaStocks · News reference
Legence Sees Q3 Sales $1.225B-$1.275B vs $1.080B Est
Legence (NASDAQ:LGN) sees Q3 sales of $1.225 billion-$1.275 billion vs $1.080 billion analyst estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 13, 2026, 11:02 AM
- Checked
- Aug 13, 2026, 11:02 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Legence Corp. (LGN)
Filed: 2026-08-18 AccNo: 0001193125-26-355583 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgarGuggenheim Reiterates Buy on Legence, Maintains $115 Price Target
Guggenheim analyst Joseph Osha reiterates Legence (NASDAQ:LGN) with a Buy and maintains $115 price target.
Read original at benzingaB of A Securities Maintains Buy on Legence, Raises Price Target to $116
B of A Securities analyst Sherif El-Sabbahy maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $105 to $116.
Read original at benzinga